ArticleEuropean journal of pharmacology2019

Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.

Yi Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.